Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Oncogene (2)
Nature Communications (2)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Amendments and Corrections (2)
Research (2)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Chemistry
Environmental sciences

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: John Glinski Clear advanced filters

Publisher Correction: Mineralogical controls on PFAS and anthropogenic anions in subsurface soils and aquifers

Marina G. Evich
James Ferreira
John W. Washington
Amendments and CorrectionsOpen Access10 Apr 2025
Nature Communications

Volume: 16, P: 1
Mineralogical controls on PFAS and anthropogenic anions in subsurface soils and aquifers

Sorption modeling treating soil as a homogenous medium misrepresents PFAS mobility in the subsurface. Exploring minerals reveals the role of aluminum-oxide electrostatics for short PFAS and organic matter and air-water interface for long-chains.

Marina G. Evich
James Ferreira
John W. Washington
ResearchOpen Access01 Apr 2025
Nature Communications

Volume: 16, P: 1-10
Correction to: BTLA⁺CD200⁺ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer

Brian Diskin
Salma Adam
George Miller
Amendments and Corrections27 Jan 2023
Oncogene

Volume: 42, P: 625
BTLA⁺CD200⁺ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer

Brian Diskin
Salma Adam
George Miller
Research10 Aug 2022
Oncogene

Volume: 41, P: 4349-4360

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Filter By:

Publisher Correction: Mineralogical controls on PFAS and anthropogenic anions in subsurface soils and aquifers

Mineralogical controls on PFAS and anthropogenic anions in subsurface soils and aquifers

Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer

BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer

Search

Quick links

Correction to: BTLA⁺CD200⁺ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer

BTLA⁺CD200⁺ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer